SEC Form 4 · accession 0001493152-15-005724
OncBioMune Pharmaceuticals, Inc · OBMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles L Rice Jr.
Director
Period of report
Nov 18, 2015
Accepted (ET)
Nov 20, 2015 · 12:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362703
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 18, 2015 | A | 60,000 | $0.00 | A | 60,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant by the issuer that was approved by the issuer's board of directors.